Analysis of CYP1A1 induction in single cells of urothelial cell populations by flow cytometry

Analytical and Bioanalytical Chemistry

Volumn 392, Issue 6, 2008, Pages 1149-1158

  Plöttner, Sabine ^a,b   Degen, Gisela H ^a   Roos, Peter H ^a   Föllmann, Wolfram ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Benzo a pyrene; Cytochrome P450 1A1 induction; Flow cytometry; Single cell analysis

Indexed keywords

AROMATIC HYDROCARBONS; CELL CULTURE; CELL PROLIFERATION; CELLS; CONCENTRATION (PROCESS); FLOW CYTOMETRY; FLUORESCENCE; HYDROCARBONS; METABOLITES; MICROSCOPIC EXAMINATION; NUCLEIC ACIDS; ORGANIC ACIDS; ORGANIC COMPOUNDS; PATHOLOGY; PHENOLS; PLANTS (BOTANY); POLYCYCLIC AROMATIC HYDROCARBONS; POPULATION STATISTICS;

AFTER-TREATMENT; AT WAVELENGTHS; BENZO [A] PYRENES; BENZO[A]PYRENE; CELL LEVELS; CYTOCHROME P450 1A1 INDUCTION; CYTOCHROMES P450; CYTOMETRIC ANALYSIS; DNA-BINDING; INDIRECT IMMUNOFLUORESCENCES; PROTEIN LEVELS; SINGLE CELLS; SINGLE-CELL ANALYSIS; STATISTICAL ANALYSIS; URINARY BLADDERS; UROTHELIAL CELLS;

CYTOLOGY;

BENZO[A]PYRENE; CYTOCHROME P450 1A1;

ANIMAL; ARTICLE; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; TIME; UROTHELIUM;

ANIMALS; BENZO(A)PYRENE; CELL LINE; CYTOCHROME P-450 CYP1A1; ENZYME INDUCTION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; TIME FACTORS; UROTHELIUM;

SUS;

EID: 54949151429     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-008-2363-7     Document Type: Article

References (49)

1. AH Conney 2003 Annu Rev Pharmacol Toxicol 43 1 30
2. MJ Coon 2005 Annu Rev Pharmacol Toxicol 45 1 25
3. FP Guengerich 2004 Drug Metab Rev 36 159 197
4. FP Guengerich 2008 Chem Res Toxicol 21 70 83
5. AY Lu 1998 Drug Metab Dispos 26 1168 1173
6. DW Nebert TP Dalton 2006 Nat Rev Cancer 6 947 960
7. FP Guengerich 2001 Chem Res Toxicol 14 611 650
8. Lang M, Pelkonen O (1999) IARC Sci Publ 13-22
9. O Hankinson 1995 Annu Rev Pharmacol Toxicol 35 307 340
10. Q Ma 2001 Curr Drug Metab 2 149 164
11. JP Whitlock Jr 1989 Trends Pharmacol Sci 10 285 288
12. JP Whitlock Jr 1999 Annu Rev Pharmacol Toxicol 39 103 125
13. AH Conney 1982 Cancer Res 42 4875 4917
14. HV Gelboin 1980 Physiol Rev 60 1107 1166
15. P Boffetta N Jourenkova P Gustavsson 1997 Cancer Causes Control 8 444 472
16. S Bonassi F Merlo N Pearce R Puntoni 1989 Int J Cancer 44 648 651
17. M, 't Kogevinas A Mannetje S Cordier U Ranft CA Gonzalez P Vineis J Chang-Claude E Lynge J Wahrendorf A Tzonou KH Jöckel C Serra S Porru M Hours E Greiser P Boffetta 2003 Cancer Causes Control 14 907 914
18. G Mastrangelo E Fadda V Marzia 1996 Environ Health Perspect 104 1166 1170
19. C Tremblay B Armstrong G Theriault J Brodeur 1995 Am J Ind Med 27 335 348
20. C Guhe GH Degen US Schuhmacher F Kiefer W Föllmann 1996 Arch Toxicol 70 599 606
21. S Plöttner A Borza A Wolf HM Bolt J Kuhlmann W Föllmann 2008 J Toxicol Env Health Part A 71 969 975
22. Plöttner S, Selinski S, Bolt HM, Degen GH, Hengstler JG, Roos PH, Föllmann W (2008) Arch Toxicol. doi: 10.1007/s00204-008-0329-3
23. A Wolf A Kutz S Plöttner C Behm HM Bolt W Föllmann J Kuhlmann 2005 Toxicology 207 255 269
24. S Plöttner S Kühnel M Koch GH Degen PH Roos W Föllmann 2008 Naunyn Schmiedeberg's Arch Pharmacol 377 65
25. S Kühnel A Dörrenhaus S Plöttner W Föllmann PH Roos 2008 Naunyn Schmiedeberg's Arch Pharmacol 377 65
26. CJ Broccardo RE Billings LS Chubb ME Andersen WH Hanneman 2004 Toxicol Sci 78 287 294
27. C Guhe W Föllmann 1994 Am J Physiol 266 F298 F308
28. E Borenfreund JA Puerner 1985 Toxicol Lett 24 119 124
29. A Dörrenhaus T Müller PH Roos 2007 Arch Toxicol 81 19 25
30. PH Roos S Tschirbs P Welge A Hack D Theegarten G Mogilevski M Wilhelm 2002 Arch Toxicol 76 326 334
31. Rubitec GmbH (2008) CYP2000 - tools for cytochrome P450 research, monoclonal antibodies for cytochromes P450. http://www.ruhr-uni-bochum.de/ rubitec/CYP2.html. Accessed 25 June 2008
32. PS Dittrich K Tachikawa A Manz 2006 Anal Chem 78 3887 3908
33. TM Keenan A Folch 2008 Lab Chip 8 34 57
34. E Cantrell M Abreu D Busbee 1976 Biochem Biophys Res Commun 70 474 479
35. HW Tyrer ET Cantrell AG Swan 1977 Life Sci 20 1723 1728
36. HW Tyrer LA Adams SM Tiffany JP O'Connell ET Cantrell 1979 J Histochem Cytochem 27 508 511
37. AG Miller JP Whitlock Jr 1981 J Biol Chem 256 2433 2437
38. AG Miller JP Whitlock Jr 1982 Cancer Res 42 4473 4478
39. AG Miller JP Whitlock Jr 1982 Mol Cell Biol 2 625 632
40. AG Miller D Israel JP Whitlock Jr 1983 J Biol Chem 258 3523 3527
41. CJ Broccardo RE Billings ME Andersen WH Hanneman 2005 Toxicol Sci 88 82 94
42. KL Stauber JD Laskin EJ Yurkow PE Thomas DL Laskin AH Conney 1995 J Pharmacol Exp Ther 273 967 976
43. CT French WH Hanneman LS Chubb RE Billings ME Andersen 2004 Toxicol Sci 78 276 286
44. W Föllmann C Guhe S Weber S Birkner S Mähler 2000 Altern Lab Anim 28 833 854
45. S Mähler E Kinne-Saffran H Fujisue RK Kinne W Föllmann 1998 Am J Physiol 274 F342 F347
46. H Jiao SL Allinson MJ Walsh R Hewitt KJ Cole DH Phillips FL Martin 2007 Mutagenesis 22 111 116
47. RP Santini S Myrand C Elferink JJ Reiners Jr 2001 J Pharmacol Exp Ther 299 718 728
48. A Levine-Fridman L Chen CJ Elferink 2004 Mol Pharmacol 65 461 469
49. Schumann CA, Dörrenhaus A, Franzke J, Lampen P, Dittrich PS, Manz A, Roos PH (2008) Anal Bioanal Chem (submitted for the Special Issue on cytochrome P450)